Skip to content

Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia

Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01236417
Enrollment
27
Registered
2010-11-08
Start date
2010-03-31
Completion date
Unknown
Last updated
2012-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthralgia, Breast Cancer

Brief summary

This is a pilot study of a specifically designed exercise intervention developed for breast cancer patients with aromatase-inhibitor related joint pain.

Interventions

BEHAVIORALExercising block

Exercising for 8 weeks using an elastic band

Sponsors

Roswell Park Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Post menopausal women with a history of estrogen positive breast cancer who are receiving aromatase inhibitors for at least one month. * Patients must complain of mild to moderate arthralgia. * Ability to understand and sign informed consent. * Patients meet criteria for low to moderate risk for moderate exercise based oon the ACSM guidelines.

Exclusion criteria

* Inability to comply with study requirements. * Metastatic breast cancer. * Patients with orthopedic or neuromuscular disorders that preclude participation in exercise. * Rheumatoid arthritis. * History of MI, angina or congestive heart failure. * Pregnant or lactating females. * Patients that are high risk for moderate exercise based on ACSM risk classification. * Patients who exceed minimal physical activity recommendations from the US Surgeon General's Report: Accumulation of 30 minutes or more of moderate physical activity on most days of the week. * Morbidly obese with BMI ≥ 40

Design outcomes

Primary

MeasureTime frameDescription
Effects of exerciseLength of studyTo assess the effect of an exercise intervention in breast cancer patients with arthralgia secondary to adjuvant treatment with aromatase inhibitors.

Secondary

MeasureTime frameDescription
Feasibility of Multi-institutional studyLength of the studyTo perform a pilot to access the feasibility of a multi-institutional approach

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026